Burzynski Research Institute, Inc.
|
-0.01 USD
|
14119.608%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
162.996%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
86.184%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
10771.642%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
4554.829%
|
Santhera Pharmaceuticals Holding AG
|
5.95 USD
|
75.966%
|
Qrons Inc.
|
-0.06 USD
|
2552.83%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
95433.333%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
2586.957%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
14400.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
126.629%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
102.816%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
2876.699%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
151.812%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
1736.156%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
6133.755%
|
Mesoblast Limited
|
-0.09 USD
|
1704.938%
|
Marizyme, Inc.
|
-1.44 USD
|
199.306%
|
Genus plc
|
0.12 USD
|
-1091.667%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
161.373%
|
Pharming Group N.V.
|
-0.02 USD
|
8981.988%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
204385.714%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
440.476%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
1581.865%
|
ContraFect Corporation
|
-124.97 USD
|
101.144%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
3504.762%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
12016.667%
|
IMV Inc.
|
-4.37 USD
|
132.723%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
4139.548%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
1430100.0%
|
Accustem Sciences Inc.
|
-0.34 USD
|
520.588%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
346.552%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
1291.667%
|
Q BioMed Inc.
|
-0.08 USD
|
1930.986%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
2134.139%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
533.333%
|
Biomind Labs Inc.
|
-0.02 USD
|
8927.16%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
100.183%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
19424.324%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
7285.93%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
59683.333%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
178850.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
650.0%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
16350.0%
|
GB Sciences, Inc.
|
-0.00 USD
|
34978.049%
|
Alpha Cognition Inc.
|
-0.15 USD
|
1053.333%
|
HST Global, Inc.
|
-0.03 USD
|
5225.448%
|
CSL Limited
|
2.73 USD
|
47.619%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
2954.291%
|
Halberd Corporation
|
-0.00 USD
|
1430100.0%
|
Enzolytics Inc.
|
-0.00 USD
|
204385.714%
|
Agentix Corp.
|
-0.04 USD
|
4185.714%
|
Resverlogix Corp.
|
-0.01 USD
|
10170.423%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
1996.552%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
argenx SE
|
-5.16 USD
|
127.713%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
-109900.0%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
-5597.211%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
4105.602%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
7250.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
2753.061%
|
Zenith Capital Corp.
|
-0.07 USD
|
2145.78%
|
Genscript Biotech Corporation
|
-0.05 USD
|
3249.78%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
22798.413%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
137.931%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
286100.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
1666.265%
|
Kadimastem Ltd
|
-0.78 USD
|
283.333%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
130.426%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
103.93%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
330.645%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
12116.807%
|
LadRx Corporation
|
0.68 USD
|
-110.294%
|
Cell Source, Inc.
|
-0.17 USD
|
941.176%
|
Regen BioPharma, Inc.
|
0.29 USD
|
-393.103%
|
Regen BioPharma, Inc.
|
0.26 USD
|
-450.0%
|
NovAccess Global Inc.
|
-0.23 USD
|
721.739%
|
Affymax, Inc.
|
-0.39 USD
|
466.667%
|
Itoco Inc.
|
-0.01 USD
|
18915.789%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
14400.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
57300.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
25635.714%
|
CytoDyn Inc.
|
-0.05 USD
|
2803.214%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
286100.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
6541.441%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
100.931%
|
SYBLEU INC
|
-0.02 USD
|
8271.429%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
10170.423%
|
International Stem Cell Corporation
|
-0.02 USD
|
8819.512%
|
Bioxytran, Inc.
|
-0.03 USD
|
4582.759%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
- USD
|
-Infinity%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
1430100.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
117.897%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
221.186%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
-0.03 USD
|
4305.882%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
22798.413%
|
Neutra Corp.
|
-0.00 USD
|
1430100.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
101.518%
|
PureTech Health plc
|
-2.38 USD
|
160.084%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
272.289%
|
IXICO plc
|
-0.02 USD
|
5960.656%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
2617.606%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
205.926%
|
CSL Limited
|
5.47 USD
|
73.857%
|
Cellectis S.A.
|
-1.77 USD
|
180.791%
|